SUBSCRIBE
SUBSCRIBE
Gail Dutton

Gail Dutton

Freelance writer

Gail Dutton is a veteran biopharmaceutical reporter, covering the industry from Washington state. You can contact her at gaildutton@gmail.com and see more of her work on Muckrack.

Business
To Achieve What’s Possible, New Freenome CEO Mike Nolan ‘Makes His Own Weather’
The new CEO of Freenome has a talent for “making his own weather.” That’s a phrase he heard often growing up in Rapid City, South Dakota and, when applied to his life and career, comes down to assessing himself accurately and looking for opportunities to contribute.
July 14, 2021
 · 
5 min read
 · 
Gail Dutton
Man vs. Machine – Which is Best at Predicting Clinical Trial Outcomes?
A recent Deny-Colton Virtual Salon pitted human intelligence against AI/ML to weigh not just the outcomes, but the process.
July 13, 2021
 · 
5 min read
 · 
Gail Dutton
Draper Achieves First SARS-CoV-2 Virus Replication in a Lung-on-a-Chip Platform
For the first time in an organ-on-a-chip model, the live SARS-CoV-2 virus has successfully infected and replicated in human tissue.
July 8, 2021
 · 
6 min read
 · 
Gail Dutton
Business
Precision BioSciences’ New CMO Touts the Value of Perseverance and Adaptation
Perseverance is the foundation of impactful scientific discoveries, and is a core value that Precision BioSciences’ newly-appointed chief medical officer, oncology giant Alan List, shares.
July 7, 2021
 · 
5 min read
 · 
Gail Dutton
Yoo-Seok Hong
Business
Culturally Nimble CEO Ready to Lead D&D Pharmatech
With business taking him throughout North and South America, Asia, and Europe, he’s learned to adapt and appreciate the nuances of a multicultural environment.
July 6, 2021
 · 
6 min read
 · 
Gail Dutton
Drug Development
Sellas Reports Promising Data from Combination Trials in Ovarian Cancer and Mesothelioma
Positive results from Sellas Life Sciences Group’s Phase I/II trial using galinpepimut-S (GPS) as a combination therapy with pembrolizumab (Keytruda®) were announced Wednesday, shortly after similarly positive news was issued from a combination study in which GPS was evaluated as a treatment for mesothelioma.
July 1, 2021
 · 
4 min read
 · 
Gail Dutton
Drug Development
New Graphene Chemeo-Phononic Test for SARS-CoV-2 May Challenge PCR Assays
Sheets of functionalized graphene quickly detected the SARS-CoV-2 virus in research conducted at the University of Illinois Chicago, paving the way for an alternative to PCR testing in the form of an accurate, real-time optical test for COVID-19.
July 1, 2021
 · 
4 min read
 · 
Gail Dutton
Business
How the U.S. Military Primed Windtree CEO Craig Fraser for C-Suite Success
Craig Fraser, CEO of Windtree Therapeutics, became a U.S. Marine at age 17, learning to perform and lead under pressure in the field before eventually leading in the C-suite.
June 30, 2021
 · 
6 min read
 · 
Gail Dutton
Innate Pharma’s ANKET NK Engager Platform Eradicates Tumors Safely and Efficiently
Innate Pharma has an alternative to T cell-based immunotherapy that has the potential to quickly and safely eradicate solid and metastatic tumors in the body.
June 30, 2021
 · 
4 min read
 · 
Gail Dutton
Business
With Spotlight on Alzheimer’s Disease and Biogen, Competitors’ Stocks Soar
It’s been a bumpy ride for Biogen as news swirls around its overall Alzheimer’s program… but not for its competitors with investigational therapies for that disease.
June 23, 2021
 · 
4 min read
 · 
Gail Dutton
Business
Scaling New Science with Big Impact is Karius CMO Brad Perkins’ Driving Force
Brad Perkins, M.D., newly appointed CMO of Karius, has had his eyes on grand scientific achievements since childhood.
June 23, 2021
 · 
5 min read
 · 
Gail Dutton
Grand Warszawski / Shutterstock
Drug Development
Roche Presents Positive Clinical Data for Neurology Programs at EAN Annual Meeting
Roche presented results from several Phase II and III trials at the 7th Congress of the European Academy of Neurology (EAN) Annual Meeting held virtually June 19-22.
June 22, 2021
 · 
5 min read
 · 
Gail Dutton
Drug Development
EAN Presenters Detail Multiple Signs of COVID-19’s Lingering Neurological Effects
Researchers at the virtual 7th Congress of the European Academy of Neurology consistently report significant, lingering cognitive and behavioral problems in multiple studies.
June 21, 2021
 · 
5 min read
 · 
Gail Dutton
Drug Development
Revive Therapeutics Advances Repurposed Drug for Mild to Moderate COVID-19
Repurposed drugs became the front-line defense against COVID-19 within a few months of the pandemic’s emergence. Now bucillamine, currently in Phase III trials in the U.S., may be poised to join them.
June 15, 2021
 · 
4 min read
 · 
Gail Dutton
Drew Angerer/Getty Images
Pharm Country
How Biotech Saved the World: Pfizer CEO Opens Up and Shares What’s Next
A sense of urgency, powerful science, relentless ingenuity, hope and trust drove the development of Pfizer and BioNTech’s mRNA vaccine during the height of the COVID-19 pandemic. As the crisis appears to lessen, Pfizer is preparing for the next pandemic.
June 15, 2021
 · 
5 min read
 · 
Gail Dutton
Load More